SOURCE: Addison-Davis Diagnostics, Inc.

August 23, 2005 11:22 ET

Addison-Davis Diagnostics Parents' Tool Drug Test to Be Marketed by National Retail Chains Throughout the U.S. Beginning First Quarter 2006 as Reported on

WESTLAKE VILLAGE, CA -- (MARKET WIRE) -- August 23, 2005 -- Addison-Davis Diagnostics, Inc. (OTC BB: ADDI) is pleased to announce that their "Parents' Tool" Drug Test Program will be marketed by national retail chains throughout the U.S. beginning in the first quarter 2006, as reported on

"Addison Davis' strategy will allow the retailers to participate in the program. This aspect of the strategy is designed to have the retailer become known as really caring for the mothers in their customer base -- an extremely good marketing step." states Larry Oakley in his column.

The "Parents' Tool" Drug Test is FDA 510K approved and self-contained NIDA (National Institute of Drug Abuse) 5-panel drug test. The "Parents' Tool" drug test will screen for Amphetamines (Crystal Meth), Cocaine, Opiates, Phencyclidine (PCP) and Marijuana (THC).

"We want to become a resource for Parents throughout the country and be viewed as a partner in their fight against drugs in their children's lives. It's time to put families first!" stated Edward W. Withrow III, CEO of Addison-Davis Diagnostics, Inc.

To read to the editorial in its entirety, please go to

About Addison-Davis

Addison-Davis Diagnostics, Inc. is responding to industry demands by supplying quick response diagnostic tests that are user friendly, produce fast simple results and are less costly, less problematic and less time consuming. Addison-Davis is currently focused on bringing fast and reliable "Point-of-care" Diagnostic Testing through the use of its patented technology to Healthcare Professionals, Hospitals, certain branches of the Government and the Workplace environment for drugs-of-abuse and medical conditions and diseases.

For more information please visit our website or contact Matt Maguire, 1-866 THE APPL(E).

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact Information